CNRC — Installation préclinique in vivo ### 📋 Eligible Entities - Biopharmaceutical companies developing biological products and vaccines - Private sector organizations seeking preclinical validation services - Research-stage biotech firms requiring in vivo testing capabilities - Domestic and international clients of the National Research Council of Canada (NRCC) - Small to large enterprises with product development programs in biologics or vaccines Note: This is a fee-for-service program, so eligibility is based on ability to contract and pay for services rather than traditional grant criteria. ### 💰 Funding Details - Nature: Paid service (not a grant subsidy) - Cost Structure: Fee-based access to CNRC's preclinical in vivo testing facilities - Funding Flow: Client pays CNRC directly for use of equipment, expertise, and facilities - No matching requirements — costs are fully borne by the client - Non-repayable — fees are service payments, not loans - Pricing: Determined on a case-by-case basis depending on scope and complexity of testing ### 🛠️ Approved Expenses - In vivo preclinical testing of biological products and vaccine candidates - Safety validation and toxicology assessment of products - Efficacy assessment in animal models prior to clinical trials - Product design approach validation to refine development strategies - Technical expertise and analysis from CNRC scientists and staff - Use of specialized laboratory equipment and facilities - Data generation to support regulatory submissions ### ⚠️ Conditions & Milestones - Client must define clear research objectives and testing protocols upfront - NRCC contract required before work commences - Compliance with regulatory standards (e.g., animal care protocols, ethical guidelines) - Proprietary protection: Clients retain intellectual property rights to their products - Timeline: Determined per project scope; typically spans several months depending on testing complexity - Reporting milestones: Progress reports and final data delivery upon completion - Facility access: Subject to NR